Bristol-Myers Squibb Company
DE ˙ XTRA ˙ US1101221083
47,44 € ↑0,88 (1,88%)
2026-06-03
DEL PRIS
SecurityDE:BRM / Bristol-Myers Squibb Company
InstitutionAsset Dedication, LLC
Latest Disclosed Ownership4,355 shares
Latest Disclosed Value $ 264,131
Asset Dedication, LLC reports 0.44% increase in ownership of BRM / Bristol-Myers Squibb Company

On May 29, 2026 - Asset Dedication, LLC filed a 13F-HR form disclosing ownership of 4,355 shares of Bristol-Myers Squibb Company (DE:BRM) valued at $228,289 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 26, 2026 disclosing 4,336 shares of Bristol-Myers Squibb Company. This represents a change in shares of 0.44% during the quarter. The current value of the position is $206,579 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-29 2026-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,355 19 0.44 264 13.30 0.0185
2026-01-26 2025-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 4,336 -2,397 -35.60 234 -23.10 0.0154
2025-11-20 2025-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 6,733 -320 -4.54 304 -7.06 0.0204
2025-08-19 2025-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 7,053 441 6.67 326 -19.11 0.0237
2025-05-01 2025-03-31 13F BRISTOL-MYERS SQUIBB COM 110122108 6,612 -7,875 -54.36 403 -50.79 0.0327
2025-01-23 2024-12-31 13F BRISTOL-MYERS SQUIBB COM 110122108 14,487 8,041 124.74 819 145.95 0.0645
2024-10-15 2024-09-30 13F BRISTOL-MYERS SQUIBB COM 110122108 6,446 -1,241 -16.14 334 4.39 0.0225
2024-08-06 2024-06-30 13F BRISTOL-MYERS SQUIBB COM 110122108 7,687 -2,936 -27.64 319 0.0221
2024-04-16 2024-03-31 13F Bristol-Myers Squibb Equities 110122108 10,623 -413 -3.74 1 0.0426
2024-02-08 2023-12-31 13F Bristol-Myers Squibb Equities 110122108 11,036 -7,036 -38.93 1 -100.00 0.0458
2023-11-13 2023-09-30 13F Bristol-Myers Squibb Equities 110122108 18,072 -163 -0.89 1 0.00 0.0893
2023-08-22 2023-06-30 13F Bristol-Myers Squibb Equities 110122108 18,235 -3,075 -14.43 1 0.00 0.0990
2023-04-24 2023-03-31 13F Bristol-Myers Squibb Equities 110122108 21,310 1,469 7.40 1 0.00 0.1373
2023-01-19 2022-12-31 13F Bristol-Myers Squibb Equities 110122108 19,841 -578 -2.83 1 -99.93 0.1451
2022-10-27 2022-09-30 13F Bristol-Myers Squibb Equities 110122108 20,419 20,419 1,455 0.1598
2022-07-18 2022-06-30 13F Bristol-Myers Squibb Equities 110122108 0 -19,668 -100.00 0 -100.00
2022-04-21 2022-03-31 13F Bristol-Myers Squibb Equities 110122108 19,668 3,561 22.11 1,437 43.56 0.1601
2022-01-21 2021-12-31 13F Bristol-Myers Squibb Equities 110122108 16,107 -4,554 -22.04 1,001 -18.15 0.1206
2021-10-18 2021-09-30 13F Bristol-Myers Squibb Equities 110122108 20,661 359 1.77 1,223 -10.01 0.1612
2021-07-21 2021-06-30 13F Bristol-Myers Squibb Equities 110122108 20,302 4,738 30.44 1,359 39.24 0.2025
2021-05-03 2021-03-31 13F Bristol-Myers Squibb Equities 110122108 15,564 -4,145 -21.03 976 -19.80 0.2205
2021-01-28 2020-12-31 13F Bristol-Myers Squibb Equities 110122108 19,709 2,369 13.66 1,217 17.02 0.2426
2020-10-20 2020-09-30 13F Bristol-Myers Squibb Equities 110122108 17,340 1,757 11.28 1,040 14.16 0.2294
2020-08-24 2020-06-30 13F Bristol-Myers Squibb Equities 110122108 15,583 976 6.68 911 11.64 0.2482
2020-05-05 2020-03-31 13F Bristol-Myers Squibb Equities 110122108 14,607 3,512 31.65 816 15.09 0.2428
2020-01-31 2019-12-31 13F Bristol-Myers Squibb Equities 110122108 11,095 1,759 18.84 709 50.21 0.2003
2019-10-17 2019-09-30 13F Bristol-Myers Squibb Equities 110122108 9,336 5,058 118.23 472 143.30 0.1569
2019-07-23 2019-06-30 13F Bristol-Myers Squibb Equities 110122108 4,278 -918 -17.67 194 -21.46 0.0626
2019-04-19 2019-03-31 13F Bristol-Myers Squibb Equities 110122108 5,196 551 11.86 247 1.65 0.0860
2019-02-12 2018-12-31 13F Bristol-Myers Squibb Equities 110122108 4,645 -499 -9.70 243 -23.58 0.0997
2018-10-26 2018-09-30 13F Bristol-Myers Squibb Equities 110122108 5,144 -241 -4.48 318 7.07 0.1195
2018-08-13 2018-06-30 13F Bristol-Myers Squibb Equities 110122108 5,385 1,089 25.35 297 9.59 0.1014
2018-04-19 2018-03-31 13F Bristol-Myers Squibb Equities 110122108 4,296 576 15.48 271 18.34 0.1344
2018-01-17 2017-12-31 13F Bristol-Myers Squibb Equities 110122108 3,720 732 24.50 229 21.16 0.0922
2017-10-18 2017-09-30 13F Bristol-Myers Squibb Equities 110122108 2,988 446 17.55 189 34.04 0.0911
2017-07-17 2017-06-30 13F Bristol-Myers Squibb Equities 110122108 2,542 0 0.00 141 1.44 0.0709
2017-04-20 2017-03-31 13F Bristol-Myers Squibb Equities 110122108 2,542 351 16.02 139 7.75 0.0751
2017-01-17 2016-12-31 13F Bristol-Myers Squibb Equities 110122108 2,191 -148 -6.33 129 0.78 0.0748
2016-11-18 2016-09-30 13F/A-2 Bristol-Myers Squibb Equities 110122108 2,339 1,850 378.32 128 255.56 0.0808
2016-10-19 2016-09-30 13F Bristol Myers Squibb Equities 110122108 440 27
2016-11-18 2016-06-30 13F/A-1 Bristol-Myers Squibb Equities 110122108 489 49 11.14 36 28.57 0.0250
2016-07-14 2016-06-30 13F Bristol Myers Squibb Equities 110122108 440 27
2016-04-27 2016-03-31 13F Bristol Myers Squibb Equities 110122108 440 -563 -56.13 28 -59.42 0.0206
2016-02-16 2015-12-31 13F Bristol Myers Squibb EQUITIES 110122108 1,003 1,003 69 0.0453
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.